企业简称:联创医药,股权代码:800055
CRO

CRO of PharmaTechnology R&D

1、Cooperative development or commissioned development of new drug;
2、Process development of API & Intermediate;
3、Impurities synthesis and preparation
4、Environment-friendly process improvement & process research for Large-scale production —— Biocatalysis technology

New drug declared in 2013-2014:

Project Name

Registration Categories

Indications

Admissibility

R&D progress

Ramelteon Tablets

3.1

Insomnia

 

Clinical Declaration

Canagliflozin Tablets

3.1

Diabetes

 

Clinical Declaration

Olanzapine fluoxetine capsules

3.2

Anxiety

 

Clinical Declaration

Dapagliflozin Tablets

3.1

Diabetes

 

Clinical Declaration

mirabegron, stained-release tablets

3.1

Incontinence

 

Clinical Declaration

Phosphorus fluconazole injection

3.1

Antifungal

 

Clinical Declaration

Retapamulin Ointment

3.1

Antibiotic

 

Clinical Declaration

更多> 联系我们

Hotline:4006515889
Tel:0551-68596228
Fax:0551-68596338
Email:sales@lcywhx.com